| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 09-06-2025 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: 2.28% As on (31-10-2025) |
| Status: Open Ended Schemes |
| Minimum Investment: 1000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 621.16 Cr As on 31-10-2025(Source:AMFI) |
| Turn over: - | Exit Load: Redemption/ switch out of units upto 10% of the units allotted before 1 year from date of allotment Exit load NIL,For redemption/switch out of units above 10% of units allotted within 1 year from the date of allotment: 1.00% of applicable NAV, For redemption/switch out of units after 1 year from the date of allotment: Nil |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
| Standard Deviation | - |
| Sharpe Ratio | - |
| Alpha | - |
| Beta | - |
| Yield to Maturity | - |
| Average Maturity | - |
Small Cap
29.64%
Others
4.47%
Large Cap
48.25%
Mid Cap
17.64%